Adar1 Capital Management, LLC Spero Therapeutics, Inc. Transaction History
Adar1 Capital Management, LLC
- $615 Billion
- Q3 2024
A detailed history of Adar1 Capital Management, LLC transactions in Spero Therapeutics, Inc. stock. As of the latest transaction made, Adar1 Capital Management, LLC holds 743,459 shares of SPRO stock, worth $877,281. This represents 0.16% of its overall portfolio holdings.
Number of Shares
743,459
Previous 918,929
19.1%
Holding current value
$877,281
Previous $1.19 Billion
16.61%
% of portfolio
0.16%
Previous 0.23%
Shares
4 transactions
Others Institutions Holding SPRO
# of Institutions
49Shares Held
13.9MCall Options Held
200Put Options Held
200-
Anson Funds Management LP Dallas, TX3.75MShares$4.43 Million0.6% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.76MShares$2.08 Million0.0% of portfolio
-
Atlas Venture Associates Ix, LLC Boston, MA1.35MShares$1.6 Million14.54% of portfolio
-
Acadian Asset Management LLC Boston, MA1.07MShares$1.26 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny975KShares$1.15 Million0.0% of portfolio
About Spero Therapeutics, Inc.
- Ticker SPRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,067,500
- Market Cap $41.4M
- Description
- Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...